TG Therapeutics
(OTCBB:TGTX)
CEO: Michael Weiss
p>This interview has expired.
Click here to find stocks, with exciting stories, and management committed to maximizing shareholder value.
TG Therapeutics (OTCBB:TGTX) CEO Interview
Newswire
- [ February 18, 2025 ] ScanTech AI (NASDAQ: STAI) Announces Initiative to Combat Contraband in Correctional Facilities Across the Americas Newsmakers
- [ February 18, 2025 ] ProPhase Labs (NASDAQ: PRPH) hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports Newsmakers
- [ February 5, 2025 ] Cumberland Pharmaceuticals (NASDAQ: CPIX) Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease Newsmakers
- [ February 5, 2025 ] Pasithea Therapeutics (NASDAQ: KTTA) Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer Newsmakers
- [ January 30, 2025 ] BigBear.ai (NYSE: BBAI)Awarded Prime IDIQ Contract for U.S. Department of Navy’s SeaPort Next Generation (NxG) Newsmakers
- [ January 30, 2025 ] ScanTech AI Systems (NASDAQ: STAI) Deploys Its Advanced AI-Driven Security Screening Technology to Protect Multiple Nuclear Power Plants Operated by Ontario Power Generation Newsmakers
- [ January 30, 2025 ] Kazia Therapeutics (NASDAQ: KZIA) announces launch of a groundbreaking trial with paxalisib in combination with immunotherapy in women with advanced breast cancer Newsmakers
- [ January 30, 2025 ] Alpha Modus (NASDAQ: AMOD) Secures 9th AI Patent, Strengthening Leadership in Retail Innovation Newsmakers
- [ January 29, 2025 ] NEWTON GOLF Company (NASDAQ: SPGC) Provides Preliminary Financial Results for Fourth Quarter 2024 and Full Year 2024 Newsmakers
- [ January 28, 2025 ] NanoVibronix (NASDAQ: NAOV)Advances Development of PainShield and UroShield with Completion of NextGen Prototypes Newsmakers
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.